Mary Coelho
Director of Finance/CFO bei GAMIDA CELL LTD.
Vermögen: 141 246 $ am 31.03.2024
Profil
Mary Theresa Coelho is currently an Independent Director at Inotiv, Inc., First Wave Biopharma, Inc., HOOKIPA Pharma, Inc., and Gamida Cell Ltd.
She is also the Chief Financial & Accounting Officer at Gamida Cell Ltd.
In the past, she held positions such as Chief Financial Officer & Treasurer at Balchem Corp., Chief Financial Officer, Treasurer & Executive VP at BioDelivery Sciences International, Inc., Chief Operating Officer at Diversey, Inc., and Global Head-Oncology Development Finance at Mars, Inc. and Novartis Pharmaceuticals Corp.
She was also the Chief Financial & Business Development Officer at CinCor Pharma, Inc. Ms. Coelho holds an MBA from Ibmec Business School and an undergraduate degree from the School of International Service.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
INOTIV, INC.
0,05% | 17.10.2023 | 12 911 ( 0,05% ) | 141 246 $ | 31.03.2024 |
GAMIDA CELL LTD.
-.--% | 12.06.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Mary Coelho
| Unternehmen | Position | Beginn |
|---|---|---|
| FIRST WAVE BIOPHARMA, INC. | Director/Board Member | 11.08.2021 |
| HOOKIPA PHARMA INC. | Director/Board Member | 03.04.2023 |
| GAMIDA CELL LTD. | Director of Finance/CFO | 22.05.2023 |
| INOTIV, INC. | Director/Board Member | 16.10.2023 |
Ehemalige bekannte Positionen von Mary Coelho
| Unternehmen | Position | Ende |
|---|---|---|
| CINCOR PHARMA, INC. | Director of Finance/CFO | 04.11.2022 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Director of Finance/CFO | 03.11.2021 |
| BALCHEM CORPORATION | Director of Finance/CFO | 26.10.2018 |
Diversey, Inc.
 Diversey, Inc. Household/Personal CareConsumer Non-Durables Diversey, Inc. engages in the provision of cleaning, sanitation, and maintenance products, systems, and services. The firm offers floor care, dilution control, kitchen care, infection prevention, fabric care, food and beverage production, building care, and personal care. The company was founded by August Koch and Herbert W. Kochs on August 4, 1923 and is headquartered in Fort Mill, NC. | Director of Finance/CFO | 01.09.2017 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01.10.2014 |
Ausbildung von Mary Coelho
| Ibmec Business School | Masters Business Admin |
| School of International Service | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| BALCHEM CORPORATION | Consumer Non-Durables |
| INOTIV, INC. | Commercial Services |
| GAMIDA CELL LTD. | Health Technology |
| FIRST WAVE BIOPHARMA, INC. | Health Technology |
| HOOKIPA PHARMA INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
Diversey, Inc.
Diversey, Inc. Household/Personal CareConsumer Non-Durables Diversey, Inc. engages in the provision of cleaning, sanitation, and maintenance products, systems, and services. The firm offers floor care, dilution control, kitchen care, infection prevention, fabric care, food and beverage production, building care, and personal care. The company was founded by August Koch and Herbert W. Kochs on August 4, 1923 and is headquartered in Fort Mill, NC. | Consumer Non-Durables |
Mars, Inc.
 Mars, Inc. Food: Specialty/CandyConsumer Non-Durables Mars, Inc. engages in the production of confectionery and animal food products. Its brands include M&M?s, Snickers, Twix, Milky Way, Dove, Pedigree, Whiskas, Extra, Skittles, Uncle Ben's, and Cocoavia. The company was founded by Franklin Clarence Mars in 1911 and is headquartered in McLean, VA. | Consumer Non-Durables |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
CinCor Pharma, Inc.
 CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology CinCor Pharma, Inc. operates as a clinical-stage biopharmaceutical company focused on developing its clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. The firm is developing CIN-107 for the treatment of multiple diseases where aldosterone plays a significant role in disease pathophysiology, including hypertension and primary aldosteronism, as well as its utility in ameliorating complications of chronic kidney disease. The company was founded by Jon Isaacsohn and Catherine Pearce on March 28, 2018 and is headquartered in Waltham, MA. | Health Technology |
